Hudson Valley Investment Advisors Inc Gsk PLC Transaction History

Hudson Valley Investment Advisors Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 15, 2021	SELL	$34.07 - $39.94 $190,212 - $222,985	-5,583 Closed	0 $0
Q1 2020 Apr 29, 2020	BUY	$32.47 - $48.83 $3,247 - $4,883	100 Added 1.82%	5,583 $212,000
Q2 2019 Jul 16, 2019	BUY	$39.4 - $42.7 $15,760 - $17,080	400 Added 7.87%	5,483 $219,000
Q1 2019 Apr 10, 2019	SELL	$38.57 - $42.69 $78,914 - $87,343	-2,046 Reduced 28.7%	5,083 $212,000
Q4 2018 Jan 17, 2019	BUY	$37.8 - $42.69 $269,476 - $304,337	7,129 New	7,129 $272,000
Q3 2018 Oct 12, 2018	SELL	$39.75 - $42.69 $204,156 - $219,255	-5,136 Closed	0 $0
Q1 2018 Apr 12, 2018	BUY	$36.18 - $40.15 $185,820 - $206,210	5,136 New	5,136 $201,000
Q4 2017 Jan 16, 2018	SELL	$35.34 - $41.9 $207,905 - $246,497	-5,883 Closed	0 $0
Q3 2017 Oct 13, 2017	BUY	$39.44 - $41.55 $232,025 - $244,438	5,883	5,883 $239,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $68.8B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Hudson Valley Investment Advisors Inc , based on Form 13F filings with the SEC.

Stay updated on Hudson Valley Investment Advisors Inc with notifications on news.